The factors of patients’ age, KPS level before operation, WHO malignancy grade, receiving radiotherapy after operation, genetic mutations in IDH1 and H3.3, and high density of CD8+ T cell infiltration, significantly affect the overall survival of brainstem glioma patients (Figure 3). The gene discussed is CD8A; the disease is brain stem glioma.